Consolidated Statements of Operations Statement (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
REVENUE:
Services	$ 188,299	$ 187,676	$ 377,034	$ 370,157
Product sales	79,263	75,463	153,431	153,909
Total revenue	267,562	263,139	530,465	524,066
OPERATING EXPENSES:
Cost of services, exclusive of depreciation expense shown below	111,706	109,661	222,277	219,814
Cost of product sales, exclusive of depreciation expense shown below	56,452	53,842	107,550	107,334
General and administrative expenses, exclusive of depreciation expense shown below	11,148	11,173	21,667	23,982
Depreciation	6,027	5,656	12,369	11,379
Amortization	291	308	582	610
Other (income) expense, net	(2,196)	630	(941)	41
OPERATING INCOME	84,134	81,869	166,961	160,906
Interest expense	2,794	2,263	5,157	4,532
Income before income tax expense	81,340	79,606	161,804	156,374
Income tax expense	17,244	19,664	36,555	39,700
Net income	64,096	59,942	125,249	116,674
Net income (loss) attributable to non-controlling interest	362	266	451	482
Net income attributable to Core Laboratories N.V.	$ 63,734	$ 59,676	$ 124,798	$ 116,192
EARNINGS PER SHARE INFORMATION:
Basic earnings per share attributable to Core Laboratories N.V. (in dollars per share)	$ 1.43	$ 1.30	$ 2.79	$ 2.52
Diluted earnings per share attributable to Core Laboratories N.V. (in dollars per share)	$ 1.42	$ 1.29	$ 2.77	$ 2.51
Cash dividends per share (in dollars per share)	$ 0.5	$ 0.32	$ 1.00	$ 0.64
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	44,660	45,841	44,783	46,020
Diluted	44,910	46,128	45,045	46,313